VYLOY (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatment of eligible* adult patients with gastric or gastroesophageal junction adenocarcinoma in India

– VYLOY is the first and only CLDN18.2-targeted treatment approved in the India for adult patients with HER2 negative gastric and gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2 positive – – Central Drugs Standard Control Organization approval was based on the global Phase 3 trials GLOW & SPOTLIGHT where the combination treatment extended median overall survival …

B L Kashyap & Sons Ltd. secures new order worth ₹91.57 crore (excl. GST) from Embassy Development Ltd in Bangalore

New Delhi, July 30, 2026: B L Kashyap & Sons Ltd. (BSE: 532719 | NSE: BLKASHYAP), one of India’s leading Engineering, Procurement, and Construction (EPC) companies, has secured a new order valued at approximately ₹91.57 crore (excluding GST) from Embassy Development Ltd. The order involves the execution of civil and structural works for the residential …